News

Bath & Body Works (BBWI) shares jumped Wednesday as the company raised its full-year earnings outloo

Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.

The cosmetics company forecast fiscal 2027 adjusted EPS of $3.10 to $3.35, with the midpoint above analyst estimates

Estee Lauder (EL) delivered earnings and revenue surprises of +21.88% and +2.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Estée Lauder Cos. posted quarterly results that beat estimates and ended a run of three straight declines in annual revenue, a sign the beauty conglomerate's turnaround efforts are gaining momentum.

(Bloomberg) -- The year was tipped to be a potential blockbuster in deals and the first half delivered, setting a pace that is likely to continue in the closing months of 2026.Most Read from BloombergSpaceX IPO Left Mirae With No Shares on MisunderstandingSupreme Court Backs Birthright Citizenship in Blow to TrumpTrump Reports at Least $1.4 Billion in 2025 Crypto EarningsWhatsApp Opens Username Reservations to 3 Billion UsersYen Hits Four-Decade Low in Historic Slide That’s Rattled JapanFrom wel

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares rose about 10% on Wednesday after the company confirmed it has ended discussions with Puig regarding a potential business combination, removing uncertainty around a deal that had been under consideration since March. In a statement,...

Estee Lauder and Puig were in talks since March 2026.

Estee Lauder shares jumped more than 11% after hours on news that talks for it to acquire the Spanish beauty group Puig have been terminated. Lauder, whose brands include Clinique, M.A.C and Bobbi Brown Cosmetics, said Thursday that it instead remains focused on its turnaround efforts.